These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 18673184)

  • 21. Metabolic implications of body fat distribution.
    Björntorp P
    Diabetes Care; 1991 Dec; 14(12):1132-43. PubMed ID: 1773700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes.
    Sullivan TJ; Miao Z; Zhao BN; Ertl LS; Wang Y; Krasinski A; Walters MJ; Powers JP; Dairaghi DJ; Baumgart T; Seitz LC; Berahovich RD; Schall TJ; Jaen JC
    Metabolism; 2013 Nov; 62(11):1623-32. PubMed ID: 23953944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Brain insulin signalling in the regulation of energy balance and peripheral metabolism.
    Diamant M
    Ideggyogy Sz; 2007 Mar; 60(3-4):97-108. PubMed ID: 17451048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic sympathetic activation: consequence and cause of age-associated obesity?
    Seals DR; Bell C
    Diabetes; 2004 Feb; 53(2):276-84. PubMed ID: 14747276
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance.
    Wang XA; Zhang R; Zhang S; Deng S; Jiang D; Zhong J; Yang L; Wang T; Hong S; Guo S; She ZG; Zhang XD; Li H
    Am J Physiol Endocrinol Metab; 2013 Aug; 305(4):E485-95. PubMed ID: 23695216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.
    Zimmet P; Boyko EJ; Collier GR; de Courten M
    Ann N Y Acad Sci; 1999 Nov; 892():25-44. PubMed ID: 10842650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crosstalk between intestinal microbiota, adipose tissue and skeletal muscle as an early event in systemic low-grade inflammation and the development of obesity and diabetes.
    Bleau C; Karelis AD; St-Pierre DH; Lamontagne L
    Diabetes Metab Res Rev; 2015 Sep; 31(6):545-61. PubMed ID: 25352002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose homeostasis, obesity and diabetes.
    Bano G
    Best Pract Res Clin Obstet Gynaecol; 2013 Oct; 27(5):715-26. PubMed ID: 23510756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects.
    Vaz M; Jennings G; Turner A; Cox H; Lambert G; Esler M
    Circulation; 1997 Nov; 96(10):3423-9. PubMed ID: 9396437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes.
    Kruse R; Vienberg SG; Vind BF; Andersen B; Højlund K
    Diabetologia; 2017 Oct; 60(10):2042-2051. PubMed ID: 28721439
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The metabolically obese, normal-weight individual revisited.
    Ruderman N; Chisholm D; Pi-Sunyer X; Schneider S
    Diabetes; 1998 May; 47(5):699-713. PubMed ID: 9588440
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sympathetic nervous system and insulin resistance: from obesity to diabetes.
    Esler M; Rumantir M; Wiesner G; Kaye D; Hastings J; Lambert G
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):304S-309S. PubMed ID: 11721888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.
    Bonen A; Tandon NN; Glatz JF; Luiken JJ; Heigenhauser GJ
    Int J Obes (Lond); 2006 Jun; 30(6):877-83. PubMed ID: 16418758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential effects of high-fat and high-carbohydrate isoenergetic meals on cardiac autonomic nervous system activity in lean and obese women.
    Tentolouris N; Tsigos C; Perea D; Koukou E; Kyriaki D; Kitsou E; Daskas S; Daifotis Z; Makrilakis K; Raptis SA; Katsilambros N
    Metabolism; 2003 Nov; 52(11):1426-32. PubMed ID: 14624401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiac autonomic nervous system activity in obesity.
    Liatis S; Tentolouris N; Katsilambros N
    Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():476-83. PubMed ID: 16444178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of fat storage via suppressed thermogenesis: a thrifty phenotype that predisposes individuals with catch-up growth to insulin resistance and obesity.
    Dulloo AG
    Horm Res; 2006; 65 Suppl 3():90-7. PubMed ID: 16612120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dysregulation of the autonomic nervous system can be a link between visceral adiposity and insulin resistance.
    Lindmark S; Lönn L; Wiklund U; Tufvesson M; Olsson T; Eriksson JW
    Obes Res; 2005 Apr; 13(4):717-28. PubMed ID: 15897481
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of orexin in the regulation of glucose homeostasis.
    Tsuneki H; Wada T; Sasaoka T
    Acta Physiol (Oxf); 2010 Mar; 198(3):335-48. PubMed ID: 19489767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Central nervous system lipocalin-type prostaglandin D2-synthase is correlated with orexigenic neuropeptides, visceral adiposity and markers of the hypothalamic-pituitary-adrenal axis in obese humans.
    Elias E; Benrick A; Behre CJ; Ekman R; Zetterberg H; Stenlöf K; Wallenius V
    J Neuroendocrinol; 2011 Jun; 23(6):501-7. PubMed ID: 21438929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.